6251 - 6260 of 8816 Results
Title
Year
-
OPENTitle: Screening of Parkinson’s Disease Using Geometric Features Extracted from Spiral DrawingsJournal Name: Brain SciencesPublisher: MDPI AGVol: 11Issue #: 10Start Page: 1297End Page: 1297Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci11101297Best OA location URL: https://www.mdpi.com/2076-3425/11/10/1297/pdf?version=1634005590Citation Count: 19
-
OPENTitle: Serum Neurofilament Light is elevated in COVID-19 Positive Adults in the ICU and is associated with Co-Morbid Cardiovascular Disease, Neurological Complications, and Acuity of IllnessJournal Name: Cardiology and Cardiovascular MedicinePublisher: Fortune JournalsVol: 05Issue #: 05Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.26502/fccm.92920221Best OA location URL: https://doi.org/10.26502/fccm.92920221Citation Count: 14
-
OPENTitle: Structural basis of polyamine transport by human ATP13A2 (PARK9)Journal Name: Molecular CellPublisher: Elsevier BVVol: 81Issue #: 22Start Page: 4635End Page: 4649.e8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.molcel.2021.08.017Best OA location URL: https://escholarship.org/content/qt0vq3x5sc/qt0vq3x5sc.pdfCitation Count: 38
-
OPENTitle: The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -IIJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.754016Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.754016/pdfCitation Count: 10
- Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis2021OPENTitle: Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia GravisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013121Best OA location URL: https://n.neurology.org/content/neurology/98/4/e376.full.pdfCitation Count: 87
-
OPENTitle: Impact of COVID-19 Pandemic on (Health) Care Situation of People with Parkinson’s Disease in Germany (Care4PD)Journal Name: Brain SciencesPublisher: MDPI AGVol: 12Issue #: 1Start Page: 62End Page: 62Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci12010062Best OA location URL: https://www.mdpi.com/2076-3425/12/1/62/pdf?version=1641260939Citation Count: 9
-
OPENTitle: Expression Quantitative Trait Loci (eQTLs) Associated with Retrotransposons Demonstrate their Modulatory Effect on the TranscriptomeJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 12Start Page: 6319End Page: 6319Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms22126319Best OA location URL: https://www.mdpi.com/1422-0067/22/12/6319/pdf?version=1624271003Citation Count: 14
-
OPENTitle: A Genetic Study of Cerebral Atherosclerosis Reveals Novel Associations with NTNG1 and CNOT3Journal Name: GenesPublisher: MDPI AGVol: 12Issue #: 6Start Page: 815End Page: 815Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes12060815Best OA location URL: https://escholarship.org/uc/item/5mx2n7cgCitation Count: 6
-
OPENTitle: Gait Analysis in Progressive Supranuclear Palsy PhenotypesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.674495Best OA location URL: https://doi.org/10.3389/fneur.2021.674495Citation Count: 15
-
OPENTitle: Low continuation of antipsychotic therapy in Parkinson disease – intolerance, ineffectiveness, or inertia?Journal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-021-02265-xBest OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-021-02265-xCitation Count: 15